Publications by authors named "Lynn K Tanoue"
Background: The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation that has occurred to combat the pandemic, have altered the balance of benefits and harms that informed current (pre-COVID-19) guideline recommendations for lung cancer screening and lung nodule evaluation. Consensus statements were developed to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic.
Materials And Methods: An expert panel of 24 members, including pulmonologists (n = 17), thoracic radiologists (n = 5), and thoracic surgeons (n = 2), was formed.
Article Synopsis
- The COVID-19 pandemic has changed how lung cancer screening and lung nodule evaluations are approached, prompting the development of new consensus statements for healthcare providers.
- A panel of 24 experts reviewed existing guidelines and voted on 12 statements addressing lung cancer screening and nodule management during the pandemic.
- The consensus indicates it is advisable to delay certain screenings and interventions to reduce exposure risks while ensuring patient safety.
Background: The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation that has occurred to combat the pandemic, have altered the balance of benefits and harms that informed current (pre-COVID-19) guideline recommendations for lung cancer screening and lung nodule evaluation. Consensus statements were developed to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic.
Methods: An expert panel of 24 members, including pulmonologists (n = 17), thoracic radiologists (n = 5), and thoracic surgeons (n = 2), was formed.